Skip to main content
Dawnrays Pharmaceutical (Holdings) Limited logo

Dawnrays Pharmaceutical (Holdings) Limited — Investor Relations & Filings

Ticker · 2348 HKEX Manufacturing
Open in API
Filings indexed 1,032 across all filing types
Latest filing 2025-11-04 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2348

About Dawnrays Pharmaceutical (Holdings) Limited

http://www.dawnrays.com

Dawnrays Pharmaceutical (Holdings) Limited is principally engaged in the development, manufacture, and sale of non-patented pharmaceutical medicines. The company specializes in cephalosporin antibiotics and a range of system-specific medicines, including cardiovascular treatments. Founded in December 1995, Dawnrays focuses on developing high-quality drugs designed to reduce patient treatment costs and meet basic market requirements. Its primary market for sales is Mainland China.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
Regulatory Filings Classification · 1% confidence The document is a Form FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” filed under the Hong Kong Exchange Listing Rules (Chapter 19B). It provides monthly movements in authorised/issued share capital, share options, and treasury shares. It is neither a financial report (Annual Report, Interim Report, Earnings Release), nor a management or board change notice, nor a dividend, proxy, M&A, or share buyback announcement. It is a routine regulatory submission with no specific matching category other than the generic Regulatory Filings. Therefore, it should be classified as RNS (General regulatory announcement/fallback).
2025-11-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025
Share Issue/Capital Change Classification · 1% confidence The document is a HKEX FF301 “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” under Listing Rule Chapter 19B, detailing movements in authorized/registered share capital, issued shares, share option exercises, etc. It is not an annual or interim report, nor an earnings release or ESG report. It is a regulatory filing specifically reporting share capital changes. Under the taxonomy, such announcements of share issues or capital changes fall under Share Issue/Capital Change (Code: SHA).
2025-10-03 English
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER - NOTICE OF PUBLICATION OF 2025 INTERIM REPORT
Report Publication Announcement Classification · 1% confidence The document is not the interim financial report itself but a corporate “Notification Letter” informing non-registered shareholders that the 2025 Interim Report has been published online and inviting them to request printed copies. It does not contain financial statements or management commentary—rather it announces the availability of another report. Under the “Menu vs Meal” rule, such notice of publication qualifies as a Report Publication Announcement (RPA), not an Interim Report (IR).
2025-09-11 English
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 INTERIM REPORT
Report Publication Announcement Classification · 1% confidence The document is a shareholder notification letter titled “Notice of publication of 2025 Interim Report.” It does not contain the interim report itself but informs shareholders that the interim report is available online and provides instructions for obtaining printed copies. This fits the definition of a Report Publication Announcement (RPA).
2025-09-11 English
2025 INTERIM REPORT
Regulatory Filings
2025-09-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025
Regulatory Filings Classification · 1% confidence The document is a standard monthly return filed with the Hong Kong Stock Exchange (HKEX) under Listing Rule Chapter 19B, detailing movements in authorised share capital, issued shares, share options, and other securities-related confirmations for the month ended 31 August 2025. It is not an earnings release, financial report, or capital-raising announcement, but rather a routine regulatory listing submission. This falls under the fallback category for miscellaneous regulatory filings.
2025-09-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.